Click here to register
Agenda
| 8.30 | COFFEE | |
| 9.00 | Welcome | Ann Van den Bruel, Director KCE Pedro Facon, CEO RIZIV-INAMI Frank Vandenbroucke, Minister of Public Health and Social Affairs |
| 9.20 | Optimising the use of approved drugs | Gauthier Bouche, Director Clinical Research, Anticancer Fund (Belgium) and Honorary Senior Researcher, UCL Innovative Clinical Trials Unit (United Kingdom) |
| 9.40 | Benefits and challenges of international clinical research programmes for treatment optimisation: focus on de-escalation strategies | Denis Lacombe CEO EORTC |
| 10.00 | Less may be better - discussing dose optimization with our patients - example of the OPT-Pembro trial | François Duhoux Head of Medical Oncology Department, Cliniques universitaires Saint-Luc and Professor, UCLouvain |
| 10.20 | Experience with treatment optimisation from health insurers in The Netherlands | Sahar Barjesteh van Waalwijk van Doorn-Khosrovani Pharmacist CZ and Associate Professor of Medical Oncology at Leiden UMC (The Netherlands) |
| 10.40 | Cost-effectiveness research: supporting better prescribing and delivering savings that cover the costs of the studies in the Netherlands | Denise van den Berg, Treatmeds Foundation (The Netherlands) |
| 11.00 | Coffee | |
| 11.40 | Highlights of the first 10 years of KCE Trials. key results from an external evaluation | Tessa Van Montfort, Director Life Sciences and Health Care Strategy, Deloitte |
| 12.00 | KCE Trials presentation | The KCE Trials team |
| 12.45 | Sandwich lunch | |
| 13.40 | Health: victim or culprit of climate change? | David Grimaldi, INAMI-RIZIV and The Shifters |
| 14.00 | Recent results of KCE Trials funded studies:
|
Maria Florencia Carbone, Clinical Research Project Nicolas Degryse, Anca Amza, Rani Soenen, |
| 15.00 | Beyond the Case Report Form: trials built on registries | Tör Biering-Sørensen Professor, Center for Translational Cardiology and Pragmatic Randomized Trials, Copenhagen University Hospital (Denmark) |
| 15.30 | Closure and networking drink | |
